MEDS Stock 12 Month Analyst Forecast
Eps Overview
Growth Next 5yrs
N/A
Last Quarter
- $1.04
Past Year
- $26.96
Growth Past 5yrs
N/A
Next Quarter
-
Estimate Next Year
-
Consensus Rating
Loading...
Consensus Price Target
Highest Price Target
N/A
0% Upside
Mean Price Target
N/A
0% Upside
Lowest Price Target
N/A
0% Upside
Recent Analyst Ratings
Upgrades, Downgrades, New Coverage
Actual EPS vs Estimated EPS
MEDS Earnings Per Share (EPS) History
According to financial reports, MEDS (NYSE: MEDS) reported an actual EPS of $-1.04 for the quarter ending on Aug 09, 2024, compared to an estimated $-0.15, resulting in a 593.33% surprise. In the prior quarter (Jun 26, 2024), MEDS recorded an actual EPS of $-6.4 with a 4166.67% surprise. See MEDS's full earnings history.
Earnings History
EPS Surprise Factor Analysis
MEDS has experienced notable EPS surprises, with the latest quarter ending Aug 09, 2024 showing a 593.33% beat. Previously, the quarter ending Jun 26, 2024 recorded a 4166.67% beat. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.
| Report Date | Actual | Forecast | Surprise Factor |
|---|---|---|---|
| Aug 09, 2024 | -1.04 | -0.15 | +593.33% |
| Jun 26, 2024 | -6.4 | -0.15 | +4,166.67% |
| Apr 22, 2024 | -12.57234 | -0.15 | +8,281.56% |
| Jan 16, 2024 | -0.07 | -0.15 | -53.33% |
| Dec 29, 2023 | -0.9 | -0.15 | +500.00% |
| Nov 06, 2023 | -0.9 | -0.15 | +500.00% |
Frequently Asked Questions
Is MEDS stock getting favorable reviews from Wall Street analysts?
Brokerage firms have given MEDS stock an average recommendation of
N/A. 0 analysts have given their ratings
to MEDS out of which
0 analysts have given strong buy call,
0 analysts have given buy call,
0 analysts rate it hold,
0 analysts advocate strong sell call, and
0 analysts has given sell rating. The average target price of
- gives the stock implied downside
of roughly 0% over the next year or so.
What have analysts suggested for MEDS highest price target?
Analysts suggest MEDS's stock price would rise to a high of -.
What is the lowest price target analysts expect for MEDS over the next year?
Within the next 12 months, analysts predict the MEDS stock price could move to -.
What is the average target price for MEDS?
MEDS stock has an average analyst estimate of -.
At its current price, how far is MEDS from its average target price?
MEDS shares are currently trading 0% below this price target.
What were MEDS’s actual earnings per share for the recent quarter?
Its quarterly earnings per share (EPS) came in at - $1.04 versus consensus estimates of - $0.15, and below the comparable year-ago quarter’s EPS of - $0.90.
What are the current estimates for quarterly and annual earnings per share?
MEDS's forecasts by analysts estimating quarterly EPS at - and - for the whole year.
What has MEDS's growth been in the past five years and what is expected in the next five years?
The analysts have projected N/A EPS growth for MEDS in the next five years, compared to growth rates of N/A in the past five years.